Lithuanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Puslapis 1 nuo 20 rezultatus
Use of texaphyrins in detection of melanin and melanin metabolites diagnostic of melanotic melanoma
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION
The present invention relates generally to the fields of cancer diagnosis, and particularly to methods for diagnosis of melanotic melanoma or metastatic melanotic melanoma. The use of texaphyrins for in vivo or in vitro detection of melanin or melanin metabolites diagnostic of
Melanin-concentrating hormones
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
This invention relates to hormones for concentrating melanin in mammals and to methods of treating mammals using such hormones.
BACKGROUND OF THE INVENTION
A cyclic heptadecapeptide which induces melanosome aggregation within fish melanophores was isolated from salmon pituitary glands, see Kawauchi,
Peptides of melanin concentrating hormone precursor
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
This invention relates to hormones for concentrating melanin in mammals and to methods of treating mammals using such hormones.
BACKGROUND OF THE INVENTION
A cyclic heptadecapeptide which induces melanosome aggregation within fish melanophores was isolated from salmon pituitary glands, see Kawauchi,
Radiolabeled antibodies for treatment of tumors
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION
The present invention relates to the imaging and treatment of melanin-containing melanomas using radiolabeled anti-melanin antibodies, and to the imaging and treatment of tumors using radiolabled antibodies that bind to a cellular component released by dying tumor
Method for treating a cancer patient based on atomic therapeutic indexes and non-radiation therapy
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION
The present invention relates to the generation of an Atomic Therapeutic Indicator (ATI) for a test sample by the quantification of manganese; in voxels of a 3D region of the sample, wherein the 3D region is topographically defined by co-ordinates X'.times.Y'.times.Z. The ATI
Applications of mussel adhesive protein product in treatment and prevention of diseases related to melanin
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
This application is a national stage application under 35 U.S.C. .sctn. 371 which claims priority of PCT Application No. PCT/CN2015/084494, filed Jul. 20, 2015.
FIELD OF THE INVENTION
The present invention substantially relates to the technical field of drugs, cosmetics, medical products,
Enhanced melanoma cancer prevention by novel melanotropins
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION
The present invention relates to melanocyte stimulating hormones (MSH), in particular, melanotropin ligands having improved selectivity, stability, and bioavailability.
BACKGROUND OF THE INVENTION
There is a critical medical need for prevention of skin damage and development
Pharmaceutical compositions and methods
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
TECHNICAL FIELD
The present inventions relate generally to compositions, kits and methods for the reduction of cellular proliferation as, for example, in the treatment of cancer.
BACKGROUND
According to the U.S. National Cancer Institute's Surveillance Epidemiology and End Results (SEER) database
Pharmaceutical compositions and methods
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
TECHNICAL FIELD
The present inventions relate generally to compositions, kits and methods for the reduction of cellular proliferation as, for example, in the treatment of cancer.
BACKGROUND
According to the U.S. National Cancer Institute's Surveillance Epidemiology and End Results (SEER) database
Pharmaceutical compositions and methods
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
TECHNICAL FIELD
The present inventions relate generally to compositions, kits and methods for the reduction of cellular proliferation as, for example, in the treatment of cancer.
BACKGROUND
According to the U.S. National Cancer Institute's Surveillance Epidemiology and End Results (SEER) database
Pharmaceutical compositions and methods
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
TECHNICAL FIELD
The present inventions relate generally to compositions, kits and methods for the reduction of cellular proliferation as, for example, in the treatment of cancer.
BACKGROUND
According to the U.S. National Cancer Institute's Surveillance Epidemiology and End Results (SEER) database
Pharmaceutical compositions and methods
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
TECHNICAL FIELD
The present inventions relate generally to compositions, kits and methods for the reduction of cellular proliferation as, for example, in the treatment of cancer.
BACKGROUND
According to the U.S. National Cancer Institute's Surveillance Epidemiology and End Results (SEER) database
Pharmaceutical compositions and methods
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
TECHNICAL FIELD
The present inventions relate generally to compositions, kits and methods for the reduction of cellular proliferation as, for example, in the treatment of cancer.
BACKGROUND
According to the U.S. National Cancer Institute's Surveillance Epidemiology and End Results (SEER) database
Pharmaceutical compositions and methods
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
TECHNICAL FIELD
The present inventions relate generally to compositions, kits and methods for the reduction of cellular proliferation as, for example, in the treatment of cancer.
BACKGROUND
According to the U.S. National Cancer Institute's Surveillance Epidemiology and End Results (SEER) database
Pharmaceutical compositions and methods
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
TECHNICAL FIELD
The present inventions relate generally to compositions, kits and methods for the reduction of cellular proliferation as, for example, in the treatment of cancer.
BACKGROUND
According to the U.S. National Cancer Institute's Surveillance Epidemiology and End Results (SEER) database
Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu
- Dirba 55 kalbomis
- Žolelių gydymas, paremtas mokslu
- Vaistažolių atpažinimas pagal vaizdą
- Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
- Skaitykite mokslines publikacijas, susijusias su jūsų paieška
- Ieškokite vaistinių žolelių pagal jų poveikį
- Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus
Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama.
* Visa informacija pagrįsta paskelbtais moksliniais tyrimais
